- Published On: January 12, 2021
Jeffrey B. Jump elected new Chairman of the Board at Texray AB
Jeffrey B. Jump is the Chairman and CEO of MedAlliance Swiss Medical Technology, with headquarters in Switzerland. He has almost 40 years of experience in the international medical technology industry, of which 15 years have been at board level.
- Published On: October 20, 2020
Texray nominated for the Global Startup Awards
Global Startup Awards is the largest independent startup ecosystem competition, with the mission to find, recognize, and connect the future shapers of the digital age from worldwide. The award is present in over 70 countries on three continents. Texray is proud to reveal that we are nominated in The Central European/Nordic Startup Award in three categories.
- Published On: September 3, 2020
Announcement: New company name, new suit and a new suite.
While our name is changing, our ownership and our product innovations remain the same. We are committed in contributing to the escalating demand for clinically validated personal protection equipment. Our focus is clear; with Texray - the first radiation protection textile in the world, we will continue to protect medical practitioners from ionizing radiation.
- Published On: June 10, 2020
LINC organizers supporting the use of HeadPeace and MindPeace
LINC (Leipzig interventional course) is a live course for different medical specialities that perform endovasular interventions and attracts around 5 000 vascular surgeons, interventional radiologists, angiologists and cardiologists from all over the world. During the annual event, LINC promoted a”ProtectYourBrain” campaign in order to increase the awareness of personal protection equipment (PPE).
- Published On: November 21, 2019
Texray presented at Heart-live in Stuttgart
Heartlive is the annual congress for interventional heart medicine within the German Cardiac Society. It is designed and organized by universities, hospitals and established physicans. It is a well-attended meeting with a high number of live cases and many didactically prepared cases. Congress attendees had the opportunity to test HeadPeace and sign up for the new product, MindPeace (patent pending, 10MD, Sweden), as soon it will become available on the European market.